Soligenix logo
Soligenix SNGX
€ 0.20 -8.33%
report update icon

Quartalsbericht 2026-Q3
hinzugefügt 06.11.2026

Soligenix Langfristige Verbindlichkeiten | SNGX

Langfristige Verbindlichkeiten Jährlich Soligenix

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
244 K - 1.12 M 234 K 9.86 M 10.1 M 6.15 K - - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
10.1 M 6.15 K 3.59 M

Langfristige Verbindlichkeiten Vierteljährlich Soligenix

2026-Q3 2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
150 K 182 K 213 K 244 K 274 K 303 K - - 11.5 K 45.7 K - 1.12 M 1.56 M 2.27 M 3.11 M 234 K 7.25 M 8.27 M 9.87 M 9.86 M 9.87 M 9.89 M 9.93 M 10.1 M 309 K 234 K 4.15 K 6.15 K 19.9 K 56.6 K 92.3 K - 191 K 682 K 803 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
10.1 M 4.15 K 2.81 M

Langfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler

Name Langfristige Verbindlichkeiten Preis % 24h Marktkapitalisierung Land
Generation Bio Co. Generation Bio Co.
GBIO
132 M - - $ 344 M usaUSA
Clearside Biomedical Clearside Biomedical
CLSD
4.72 M - - $ 25.3 M usaUSA
Merus N.V. Merus N.V.
MRUS
95.3 M - - $ 5.78 B niderlandNiderland
RAPT Therapeutics RAPT Therapeutics
RAPT
2.22 M - - $ 2.36 B usaUSA
Annexon Annexon
ANNX
23.3 M $ 3.11 -8.94 % $ 482 M usaUSA
Acasti Pharma Acasti Pharma
ACST
612 K - 4.01 % $ 150 M canadaCanada
Aptose Biosciences Aptose Biosciences
APTO
27.9 M - -45.71 % $ 1.2 M canadaCanada
Galapagos NV Galapagos NV
GLPG
17.8 M - - $ 1.83 B belgiumBelgium
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
2 K - -4.36 % $ 27 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
2.03 M - -52.27 % $ 4.45 M usaUSA
Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd.
GLMD
44 K $ 4.63 21.05 % $ 20 M israelIsrael
Achieve Life Sciences Achieve Life Sciences
ACHV
11.2 M $ 6.78 0.89 % $ 296 M usaUSA
Leap Therapeutics Leap Therapeutics
LPTX
5.12 M - 368.57 % $ 41.9 M usaUSA
Lumos Pharma Lumos Pharma
LUMO
6 M - - $ 35.3 M usaUSA
Gamida Cell Ltd. Gamida Cell Ltd.
GMDA
35.2 M - -18.25 % $ 5.04 M israelIsrael
Axcella Health Axcella Health
AXLA
615 K - -16.42 % $ 249 M usaUSA
Metacrine Metacrine
MTCR
10.9 M - - $ 24.2 M usaUSA
Zealand Pharma A/S Zealand Pharma A/S
ZEAL
806 M - 0.52 % $ 821 M danmarkDanmark
Myovant Sciences Ltd. Myovant Sciences Ltd.
MYOV
743 M - -0.04 % $ 2.62 B usaUSA
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
1.93 M - -74.18 % $ 955 K usaUSA
Idera Pharmaceuticals Idera Pharmaceuticals
IDRA
127 M - -23.04 % $ 26.6 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
36 M - - $ 3.67 B usaUSA
Verona Pharma plc Verona Pharma plc
VRNA
227 M - - $ 69.7 B britainBritain
Atreca Atreca
BCEL
12.6 M - -11.76 % $ 5.79 M usaUSA
Guardion Health Sciences Guardion Health Sciences
GHSI
272 K - -0.31 % $ 3.64 M usaUSA
Opiant Pharmaceuticals Opiant Pharmaceuticals
OPNT
18.7 M - - $ 109 M usaUSA
Akouos Akouos
AKUS
12 M - 0.23 % $ 488 M usaUSA
ImmunoGen ImmunoGen
IMGN
234 M - - $ 7.92 B usaUSA
Vascular Biogenics Ltd. Vascular Biogenics Ltd.
VBLT
477 K - -8.77 % $ 12.4 M israelIsrael
Cidara Therapeutics Cidara Therapeutics
CDTX
1.93 M - - $ 1.41 B usaUSA
Iterum Therapeutics Iterum Therapeutics
ITRM
15 M - - $ 591 K irlandaIrlanda
Navidea Biopharmaceuticals Navidea Biopharmaceuticals
NAVB
996 K - -2.99 % $ 2.47 M usaUSA
Stealth BioTherapeutics Corp Stealth BioTherapeutics Corp
MITO
25.2 M - - $ 23.9 M usaUSA
OncoSec Medical Incorporated OncoSec Medical Incorporated
ONCS
9.13 M - 31.87 % $ 1.61 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
78.7 M - -4.8 % $ 255 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
79.1 M - -0.23 % $ 916 M usaUSA
bluebird bio bluebird bio
BLUE
170 M - - $ 546 M usaUSA
Landos Biopharma Landos Biopharma
LABP
276 K - 0.58 % $ 144 M usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
12.3 M - - $ 35.4 M usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
9.41 M - -5.16 % $ 5.39 M usaUSA
Sigilon Therapeutics Sigilon Therapeutics
SGTX
31.9 M - - $ 728 M usaUSA
Regulus Therapeutics Regulus Therapeutics
RGLS
274 K - - $ 155 M usaUSA
NGM Biopharmaceuticals NGM Biopharmaceuticals
NGM
9.97 M - - $ 127 M usaUSA
Aravive Aravive
ARAV
10.2 M - -13.39 % $ 1.45 M usaUSA
Crinetics Pharmaceuticals Crinetics Pharmaceuticals
CRNX
4.9 M $ 84.95 0.13 % $ 7.99 B usaUSA
Acer Therapeutics Acer Therapeutics
ACER
244 K - 2.71 % $ 14 M usaUSA
Gilead Sciences Gilead Sciences
GILD
29.2 B $ 166.01 -0.31 % $ 207 B usaUSA
Assembly Biosciences Assembly Biosciences
ASMB
2.06 M $ 22.14 -1.6 % $ 248 M usaUSA